Get breaking news and analysis on Achillion Pharmaceuticals, Inc. (ACHN) stock, price quote and chart, trading and investing tools. Achillion Pharmaceuticals Stock Price History + Charts (ACHN) The following presents a detailed Achillion Pharmaceuticals stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Achillion Pharmaceuticals stock chart which you can easily adjust to the time frame of your choosing (e.g. using the scroll bar or pinch and zoom on a touch screen). Achillion Pharmaceuticals - ACHN - Stock Price & News ... Real time Achillion Pharmaceuticals (ACHN) stock price quote, stock graph, news & analysis. Real time Achillion Pharmaceuticals (ACHN) stock price quote, stock graph, news & analysis.
Achillion Pharmaceuticals (ACHN) has 0 splits in our ACHN split history database.. Looking at the ACHN split history from start to finish, an original position size … ACHN Price Target and Analyst Ratings (Achillion ... Nov 01, 2019 · Their average twelve-month price target is $4.40, suggesting that the stock has a possible downside of 34.91%. The high price target for ACHN is $6.30 and the low price target for ACHN is $2.50. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus rating of "Hold." - ACHN - Stock Price Today - Zacks
Pharmasset Acquired, Shares Jump 85% | The Motley Fool Oddly, Achillion (Nasdaq: ACHN), with three hep-C drugs in development, is up only 3%, but the stock saw shares pop last week when the company's CEO got the market excited about a potential buyout.
The historical data and Price History for Achillion Pharmaceuticals (ACHN) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. ACHN - MarketWatch: Stock Market News
Achillion Pharmaceuticals Stock Chart - ACHN Achillion Pharmaceuticals (ACHN) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ACST Stock Price and Chart — NASDAQ:ACST — TradingView Since breaking-out last October'18, ACASTI PHARMA INC - NASDAQ:ACST has been trading in a side-ways grind with no real progress towards higher levels to speak of. However, we've been monitoring the action closely for some time now and it appears that ACST may just be starting to pick its head up as evidenced in the Daily chart above.